Agape ATP Corporation (ATPC)
NASDAQ: ATPC · Real-Time Price · USD
1.650
+0.090 (5.77%)
At close: May 12, 2025, 4:00 PM
1.630
-0.020 (-1.21%)
After-hours: May 12, 2025, 7:57 PM EDT

Company Description

Agape ATP Corporation, an investment holding company, supplies health and wellness products and health solution advisory services in Malaysia.

The company operates through Skin care, health and wellness; and Green energy segments. It offers two series of programs that consist of various services and products under the ATP Zeta Health Program and E.A.T.S.

names. The company also provides ionized and high bioavailability nutrients to enhance absorption at the cellular level, energized mineral concentrate, soy protein isolate powder, LIVO5, and solutions for sustainability and energy savings; and promotes environmental stewardship.

In addition, it promotes wellness and wellbeing lifestyle through online editorials, programs, events, and campaigns, as well as provides health therapies.

Further, the company provides renewable energy products, technical solutions, installations, and maintenance services.

Agape ATP Corporation was incorporated in 2016 and is headquartered in Kuala Lumpur, Malaysia.

Agape ATP Corporation
Agape ATP logo
Country Malaysia
Founded 2016
Industry Packaged Foods
Sector Consumer Staples
Employees 16
CEO Kok Choong How

Contact Details

Address:
Lot 1705 – 1708, Faber Towers, Level 17, Tower 2
Kuala Lumpur, 58100
Malaysia
Phone 60 1 9223 0099
Website atpc.com.my

Stock Details

Ticker Symbol ATPC
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001713210
CUSIP Number 008389108
ISIN Number US0083891087
Employer ID 36-4838886
SIC Code 8000

Key Executives

Name Position
Dr. Kok Choong How Chairman of the Board, Founder, Group Chief Executive Officer, President, Chief Operating Officer, Treasurer and Secretary
Kam Fan Lee CPA Chief Financial Officer
Wan Lock Ting Vice President of Corporate Finance
Dr. Wilfrendo Fernando Cortizo Ph.D. Executive Director

Latest SEC Filings

Date Type Title
Apr 22, 2025 424B3 Prospectus
Apr 21, 2025 EFFECT Notice of Effectiveness
Apr 16, 2025 S-1/A [Amend] General form for registration of securities under the Securities Act of 1933
Apr 11, 2025 S-1 General form for registration of securities under the Securities Act of 1933
Apr 3, 2025 8-K Current Report
Mar 31, 2025 10-K Annual Report
Mar 31, 2025 SCHEDULE 13G Filing
Mar 31, 2025 SCHEDULE 13G Filing
Mar 31, 2025 SCHEDULE 13G Filing
Mar 31, 2025 SCHEDULE 13G Filing